-
SBI Healthcare Opportunities Fund Regular Reinvestment Inc Dist cum Cap Wdrl
Equity healthcare
Overview ( as on 25/07/24 )
NAV
₹234.61
Last change
₹2.1 +0.01%
Fund Size (AUM)
2760.05 Cr
Performance
27.91% (5Y)
Fund Details
SBI Healthcare Opportunities Fund Regular Reinvestment Inc Dist cum Cap Wdrl
as of 25/07/24
AUM
2760.05 Cr
Expense Ratio
2.0 %
Benchmark
BSE Healthcare TR INR
ISIN
INF200K01461
Fund Manager
Tanmaya Desai
Exit Load
0.5% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| SBI Healthcare Opportunities Fund Regular Reinvestment Inc Dist cum Cap Wdrl | 37.15% | 16.33% | 27.91% |
| BSE Healthcare TR INR | 43.76% | 13.19% | 23.55% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
13.78% |
Max Healthcare Institute Ltd Ordinary Shares |
7.67% |
Divi's Laboratories Ltd |
6.66% |
Cipla Ltd |
6.65% |
Aether Industries Ltd |
4.68% |
Jupiter Life Line Hospitals Ltd |
4.08% |
Aurobindo Pharma Ltd |
3.94% |
Mankind Pharma Ltd |
3.86% |
Krishna Institute of Medical Sciences Ltd |
3.78% |
Abbott India Ltd |
3.6% |
Sector Allocation
Healthcare |
92.75% |
Basic Materials |
7.25% |
Asset Allocation
-
98%
Equity
-
2%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
28.95% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
29.58% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
27.91% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
27.91% (5Y)
-
-
Tata India Pharma & Healthcare Reg Gr
Equity healthcare-
Returns
-
25.83% (5Y)
-
-
Tata India Pharma & Healthcare RegIDCW-R
Equity healthcare-
Returns
-
25.83% (5Y)
-
